Vimarsana
Biggest News Aggregation in the World

Page 2 - Development Rd Dr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development Rd Dr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Rd Dr Today - Breaking & Trending Today

VCO as possible adjunct treatment vs COVID: What you need to know - Vimarsana News

VCO as possible adjunct treatment vs COVID: What you need to know

The Philippines has conducted clinical studies to determine the efficacy of virgin coconut oil (VCO) as adjunct treatment against coronavirus disease (COVID-19). (MANILA BULLETIN FILE PHOTO ) Department of Science and Technology (DOST) Undersecretary for Research and Development (R&D) Dr. R

Source: mb.com.ph
Recruitment of participants for WHO Solidarity Vaccine Trial 'piloted' in 3 hospitals in Metro Manila —DOST – Manila Bulletin - Vimarsana News

Recruitment of participants for WHO Solidarity Vaccine Trial 'piloted' in 3 hospitals in Metro Manila —DOST – Manila Bulletin

The recruitment of participants for the World Health Organization’s (WHO) Solidarity Vaccines Trial (SVT) has been piloted in three hospitals in Metro Manila, the Department of Science and Technology (DOST) said. (MANILA BULLETIN FILE PHOTO) DOST Undersecretary for Research and Development (R&a

Source: mb.com.ph
Recruitment of 1,464 Ivermectin trial participants to start in November - Vimarsana News

Recruitment of 1,464 Ivermectin trial participants to start in November

The Department of Science and Technology (DOST) said Saturday, Oct. 23, said the recruitment of over 1,400 participants for the eight month-long clinical Ivermectin clinical trials is expected to start in November, and that the initial results of the study may be out by end of December this year.

Source: mb.com.ph
DOST: PH COVID-19 vaccine 'mix and match' trial may start soon – Manila Bulletin - Vimarsana News

DOST: PH COVID-19 vaccine 'mix and match' trial may start soon – Manila Bulletin

The Philippines’ study on the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and vaccine platforms in Filipino adults may start soon. (MANILA BULLETIN FILE PHOTO) During his weekly report on Friday, Oct. 22, Department of Science and Technology (DOST) Secr

Source: mb.com.ph
Inauguration of BSL-2 lab part of preparation for VIP — DOST - Vimarsana News

Inauguration of BSL-2 lab part of preparation for VIP — DOST

The Department of Science and Technology (DOST) inaugurated Thursday, Oct. 21, its Biosafety Level 2+ (BSL-2) Laboratory which will enable country’s researchers to work on different virology projects — from plant and animal to human virology in preparation for the upcoming establishment of the Virol

Source: mb.com.ph